Filing Details

Accession Number:
0001179110-18-000780
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-01-09 18:12:17
Reporting Period:
2018-01-05
Accepted Time:
2018-01-09 18:12:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1260990 Gtx Inc GTXI Pharmaceutical Preparations (2834) 621715807
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1595312 T Jason Shackelford 175 Toyota Plaza
7Th Floor
Memphis TN 38103
Prin Fin. & Acct. Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-01-05 711 $12.02 31,111 No 4 S Direct
Common Stock Disposition 2018-01-05 2,379 $11.13 28,732 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 60 Indirect By IRA
Common Stock 35 Indirect By Spouse IRA
Footnotes
  1. Shares sold to satisfy tax withholding obligations arising out of the vesting of a portion of previously granted restricted stock units.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $11.61 to $12.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.81 to $11.60, inclusive.